Pacesetter

Amgen’s partnership with the Arthritis Foundation has spanned more than 16 years, during which they have been the National Presenting Sponsor of Walk to Cure Arthritis. Amgen has also been the Presenting Sponsor of the California Coast Classic with several employees participating in the 5-day trek. In addition, they continue to support several educational programs which allows the Arthritis Foundation to develop and expand resources for our patient and caregiver community. Amgen’s annual partnership and investment in our mission provides programs that impact the lives of people living with arthritis. Amgen has also received the Arthritis Foundation’s Ease of Use seal for their prescription medical device and Embark app. To learn more about Amgen, please visit https://www.amgen.com.

Bristol Myers Squibb (BMS) is proud to be a long-time partner of the Arthritis Foundation and is committed to supporting the arthritis community through education and empowerment. In addition to being a sponsor and participant in the Walk to Cure Arthritis and Jingle Bell Run, BMS also supports the Arthritis Foundation’s local and national programs for patients and their families, including diversity and health equity work, advocacy efforts, and juvenile arthritis initiatives. To learn more about BMS, visit www.bms.com.

Janssen, a Johnson & Johnson Company, has been a long-standing sponsor of Walk to Cure Arthritis and Jingle Bell Run events the Arthritis Foundation and its constituents. Their teams are always ready to engage at the community level and advance the patient voice and awareness for the arthritis community. Janssen also supports the Arthritis Foundation’s advocacy efforts, patient education initiatives, and diversity and health equity work. Janssen has also earned the Arthritis Foundation’s Ease of Use Certification for their prescription medical device.  To learn more about Janssen, please visit www.janssen.com.

In our collaborative partnership, Novartis Pharmaceuticals supports the Arthritis Foundation’s programs including but not limited to, juvenile arthritis. Osteoarthritis and psoriatic arthritis as well as our many advocacy efforts. advocacy efforts, the CARRA Annual Scientific Meeting, OA initiatives, and SJIA education. To learn more about Novartis Pharmaceuticals, please visit www.novartis.com.